Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report.

Springer, CNS Drugs, 4(35), p. 439-450, 2021

Journal article published in 2021 by Emma Morton, Daniel J. Müller, Sagar V. Parikh, Susan Rotzinger, Venkat Bhat, Peter Giacobbe, Wendy Lou, Erin E. Michalak, Shane McInerney, Trisha Chakrabarty, Benicio N. Frey

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by